A new meta-analysis of 31 preclinical studies suggests GLP-1 drugs like semaglutide may reduce ischemic stroke severity in ...

Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects. Brain scientists are looking for ways ...

Remedy Meds is an online consumer health and pharmacy platform that provides access to compounded glucagon-like peptide-one ...

Once-weekly semaglutide 2.4 mg reduced the risk for major adverse cardiovascular events among adults with overweight or obesity who were at risk for atherosclerotic cardiovascular disease, according ...

U.S. researchers are beginning to identify clinical characteristics that distinguish “super responders” to GLP-1 weight-loss ...

Novo Nordisk goes "on the offensive" following Trump deal that also included rival Eli Lilly, putting an exclamation point on ...

Last year, the U.S. Food and Drug Administration banned the sale of compounded weight loss drugs, which are often much ...

Novo Nordisk offers Wegovy and Ozempic at $199/month for new self-pay patients, valid for the first two months until March 31, 2026. The promotion aligns with a national agreement to improve access ...

The drugmaker said Monday that it has started selling higher doses of the injectable obesity treatment for $349 a month to ...

The maker of the weight loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of the blockbuster ...

Priority voucher awardees and regulators could feel pressure to “meet the moment” as FDA watchers question the intent and ...

Wegovy and Zepbound are 2 FDA-approved injectables for weight loss. Learn how they compare in benefits, side effects, and ...